Novavax | 4: Statement of changes in beneficial ownership of securities-Officer O'Hara Elaine
Novavax | 4: Statement of changes in beneficial ownership of securities
諾瓦瓦克斯醫藥 | 4：持股變動聲明
牛牛AI助理已提取核心訊息
Elaine O'Hara, EVP, Chief Strategy Officer at Novavax, Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. This information is critical for investors to understand the potential impact on their investment in Novavax.
Elaine O'Hara, EVP, Chief Strategy Officer at Novavax, Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. This information is critical for investors to understand the potential impact on their investment in Novavax.
據報道，Novavax, Inc. [NVAX] 執行副總裁兼首席戰略官伊萊恩·奧哈拉於2024年3月1日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。這些信息對於投資者了解對Novavax投資的潛在影響至關重要。
據報道，Novavax, Inc. [NVAX] 執行副總裁兼首席戰略官伊萊恩·奧哈拉於2024年3月1日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。這些信息對於投資者了解對Novavax投資的潛在影響至關重要。
有用
沒用
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了